Conditions: Diabetic Kidney Disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 319
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether BMS-813160 will reduce the amount of protein loss in the urine of subjects with type 2 diabetes and diabetic kidney disease

Detailed description:

Arms:
arm 1: BMS-813160 150 mg capsules by mouth in AM and Placebo matching with BMS-813160 in PM for 12 weeks arm 2: BMS-813160 300 mg capsules by mouth twice daily for 12 weeks arm 3: Placebo matching with BMS-813160 0 mg capsules by mouth twice daily for 12 weeks

Interventions: intervention 1: BMS-813160 intervention 2: Placebo matching with BMS-813160
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: